-
Something wrong with this record ?
Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease
D. Galuška, L. Pácal, K. Kaňková
Language English Country Switzerland
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2010
ProQuest Central
from 1994-05-01 to 1 year ago
ProQuest Central
from 2017-01-01
Open Access Digital Library
from 2013-01-01
Medline Complete (EBSCOhost)
from 2005-01-01
Health & Medicine (ProQuest)
from 1994-05-01 to 1 year ago
Health & Medicine (ProQuest)
from 2017-01-01
Karger Open Access
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
PubMed
33756482
DOI
10.1159/000514286
Knihovny.cz E-resources
- MeSH
- COVID-19 metabolism MeSH
- Diabetes Mellitus drug therapy etiology metabolism physiopathology MeSH
- Diabetic Nephropathies drug therapy etiology metabolism physiopathology MeSH
- Humans MeSH
- Vitamin D Deficiency complications drug therapy metabolism physiopathology MeSH
- Signal Transduction drug effects MeSH
- Vitamin D metabolism therapeutic use MeSH
- Vitamins metabolism therapeutic use MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Vitamin D is a hormone regulating not only calcium and phosphate homeostasis but also, at the same time, exerting many other extraskeletal functions via genomic effects (gene transcription) and probably by non-genomic effects as well. Availability is ensured by dietary intake of its precursors and by de novo production via sunlight. Yet, vitamin D deficiency and insufficiency are very common across the globe and are connected to many pathophysiological states, for example, diabetes mellitus, allergies, autoimmune diseases, pregnancy complications, and recently have also been associated with worse COVID-19 clinical outcomes. SUMMARY: In this review, we summarize current knowledge about vitamin D metabolism in general, its role in diabetes mellitus (mainly type 2) and diabetic complications (mainly diabetic kidney disease), and potential therapeutic perspectives including vitamin D signalling as a druggable target. Key Messages: Vitamin D is not only a vitamin but also a hormone involved in many physiological processes. Its insufficiency or deficiency can lead to many pathological states.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019572
- 003
- CZ-PrNML
- 005
- 20210830101151.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000514286 $2 doi
- 035 __
- $a (PubMed)33756482
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Galuška, David $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czechia, 423585@mail.muni.cz
- 245 10
- $a Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease / $c D. Galuška, L. Pácal, K. Kaňková
- 520 9_
- $a BACKGROUND: Vitamin D is a hormone regulating not only calcium and phosphate homeostasis but also, at the same time, exerting many other extraskeletal functions via genomic effects (gene transcription) and probably by non-genomic effects as well. Availability is ensured by dietary intake of its precursors and by de novo production via sunlight. Yet, vitamin D deficiency and insufficiency are very common across the globe and are connected to many pathophysiological states, for example, diabetes mellitus, allergies, autoimmune diseases, pregnancy complications, and recently have also been associated with worse COVID-19 clinical outcomes. SUMMARY: In this review, we summarize current knowledge about vitamin D metabolism in general, its role in diabetes mellitus (mainly type 2) and diabetic complications (mainly diabetic kidney disease), and potential therapeutic perspectives including vitamin D signalling as a druggable target. Key Messages: Vitamin D is not only a vitamin but also a hormone involved in many physiological processes. Its insufficiency or deficiency can lead to many pathological states.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a COVID-19 $x metabolismus $7 D000086382
- 650 _2
- $a diabetes mellitus $x farmakoterapie $x etiologie $x metabolismus $x patofyziologie $7 D003920
- 650 _2
- $a diabetické nefropatie $x farmakoterapie $x etiologie $x metabolismus $x patofyziologie $7 D003928
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a vitamin D $x metabolismus $x terapeutické užití $7 D014807
- 650 _2
- $a nedostatek vitaminu D $x komplikace $x farmakoterapie $x metabolismus $x patofyziologie $7 D014808
- 650 _2
- $a vitaminy $x metabolismus $x terapeutické užití $7 D014815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pácal, Lukáš $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czechia
- 700 1_
- $a Kaňková, Kateřina $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czechia
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 46, č. 2 (2021), s. 152-161
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33756482 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101151 $b ABA008
- 999 __
- $a ok $b bmc $g 1690413 $s 1140018
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 46 $c 2 $d 152-161 $e 20210323 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- LZP __
- $a Pubmed-20210728